MRNAon logo

Moderna Inc (MRNA)

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficien...

NASDAQHealthcareBiotechnologyUSA

Company Profile

Stock Code
MRNA
ISIN Code
US60770K1079
Currency
US Dollar (USD)
IPO Date
2018-12-07

Contact Information

Company Address
325 Binney Street, Cambridge, MA, United States, 02142
Contact Phone
617 714 6500
Company Website
https://www.modernatx.com
Fiscal Year End
December

Financial Highlights

Market Capitalization
$999,999.99
Gross Profit (TTM)
$-999,999.99
Return on Assets (TTM)
-13.09%
EBITDA
$-999,999.99
Revenue (TTM)
$999,999.99